Executive Director of Global Government Affairs | Amgen
Driven by a passion to serve patients, Chad Pettit, Executive Director of Global Government Affairs at Amgen, brings extensive expertise in commercial strategy, biosimilar, and healthcare policy. He is a leading advocate for the vital role biosimilars play in ensuring health system sustainability, advocating for policy solutions that support a sustainable biologics medicines marketplace with biosimilars.
In his previous role as Executive Director of Marketing for Amgen’s Biosimilars Business Unit, Chad led the Global Biosimilars Commercial Team in developing global strategies for Amgen’s portfolio of 11 biosimilar medicines and future pipeline. He has also served as a spokesperson on biosimilars for Amgen in the biopharmaceutical industry. Throughout his tenure at Amgen, Chad has held commercial roles across the US, Europe, and global markets, focusing on pricing, market access, and marketing.
Chad holds an MBA from the UCLA Anderson School of Management and a B.S. in Chemical Engineering from the University of California Davis. In addition to his professional accomplishments, he is deeply committed to leadership and service within the community.
